PARTNER NEWS:Tue, May 7, 4:40 AM, Zacks
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand have been highlighted in this Industry Outlook article.
Mon, May 6, 7:50 AM, Zacks
5 Biotech Stocks Worth Adding to Your Portfolio in 2024 New drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position BMRN, BPMC, IMVT, KYMR and LGND well amid volatility.
Featured MNV Articles: Skyworks Solutions Named Top Dividend Stock With Insider Buying and 2.95% Yield (SWKS)
Friday, May 10, 5:53 PM ET, by Market News Video Staff
In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then ...
Bullish Two Hundred Day Moving Average Cross - MTRN
Friday, May 10, 5:53 PM ET, by Market News Video Staff
In trading on Friday, shares of Materion Corp (MTRN) crossed above their 200 day moving ...
THO Crosses Above Key Moving Average Level
Friday, May 10, 5:53 PM ET, by Market News Video Staff
In trading on Friday, shares of Thor Industries, Inc. (THO) crossed above their 200 day ...
Bullish Two Hundred Day Moving Average Cross - MTRN
Friday, May 10, 5:52 PM ET, by Market News Video Staff
In trading on Friday, shares of Materion Corp (MTRN) crossed above their 200 day moving ...
Notable Two Hundred Day Moving Average Cross - F
Friday, May 10, 5:51 PM ET, by Market News Video Staff
In trading on Friday, shares of Ford Motor Co. (F) crossed below their 200 day ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|